A common and usually harmless virus may improve the outcomes of a skin cancer treatment, according to research from the University of Oxford.

When Roy Bradley was told he had cancer in his lungs and liver, his first thought was he couldn't face chemotherapy and ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center ...

A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...

Skin cancer is by far the most common type of cancer, according to the American Cancer Society, and it’s also on the rise. We ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

A new study led by scientists at the University of Oxford has revealed something surprising: a common virus carried by more ...

For those with surface skin cancer, new technology offers a non-surgical treatment option. Dr. Muennich is among the few in ...